Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis - EurekAlert
Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib, according to results from the international Phase III MOMENTUM trial l…
Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib, according … [+3956 chars]
Read More
Other Stories in Health
- 3 nutrients that work best to improve memory and intelligence
- Can Combined Renal Function Markers & Blood Lipid Levels Predict PE?
- Exclusive: World Cancer Day 2025 - 'India Will See Rise Of 12% To 18% In Cancer Cases', Why Are People More at Risk In Recent Times
- How My Ex and I Created a Beautiful Friendship
- Weekly Horoscope For January 27-February 2, From The AstroTwins
- EMCrit 393 – CV-EMCrit – Inotrope Basics Part 1
- How to ace the perfect tri-colour makeup on Republic Day 2025
- Immune environment found to influence success of leukemia immunotherapy
- University Hospitals introduces endoscopic spine surgery for back pain patients with herniated discs
.png)
